Gossamer Bio, Inc. GOSS
- seralutinib — Pulmonary Arterial Hypertension NDA Submitted
- seralutinib — Pulmonary Hypertension associated with Interstitial Lung Disease Phase 3
CSF-1R (3 companies · 4 programs)
Companies with an active program directed at CSF-1R.
Adagene Inc. ADAG
- ADG125 Phase 2
Syndax Pharmaceuticals Inc SNDX
- Niktimvo — Chronic Graft-Versus-Host Disease Approved